ArticleJournal of biomedical semantics2026
Annotating and indexing scientific articles with rare diseases.
Article in Journal of biomedical semantics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAround 30 million people in Europe are affected by a rare (or orphan) disease, defined as a condition occurring in fewer than 1 in 2,000 individuals. The primary challenge is to automatically and efficiently identify scientific articles and guidelines that address a particular rare disease. We present a novel methodology to annotate and index scientific text with taxonomical concepts describing rare diseases from the OrphaNet taxonomy. This task is complicated by several technical challenges, including the lack of sufficiently large, human-annotated datasets for supervised training and the polysemy/synonymy and surface-form variation of rare disease names, which can hinder any annotation engine.
resultsWe introduce a framework that operationalizes OrphaNet for large-scale literature annotation by integrating the TERMite engine with curated synonym expansion, label normalization (including deprecated/renamed concepts), and fuzzy matching. On benchmark datasets, the approach achieves precision = 92%, recall = 75%, and F1 = 83%, outperforming an string-matching baseline. Applying the pipeline to Scopus produces disease-specific corpora suitable for bibliometric and scientometric analyses (e.g., institution, country, and subject-area profiles). These outputs power the Rare Diseases Monitor dashboard for exploring national and global research activity.
conclusionTo our knowledge, this is the first systematic, scalable semantic framework for annotating and indexing rare disease literature at scale. By operationalizing OrphaNet in an automated, reproducible pipeline and addressing data scarcity and lexical variability, the work advances biomedical semantics for rare diseases and enables disease-centric monitoring, evaluation, and discovery across the research landscape.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.